1. Home
  2. Author
  3. Perhach JL

Perhach JL

References (2)

Title : The safety, tolerability, and efficacy of once-daily memantine (28 mg): a multinational, randomized, double-blind, placebo-controlled trial in patients with moderate-to-severe Alzheimer's disease taking cholinesterase inhibitors - Grossberg_2013_CNS.Drugs_27_469
Author(s) : Grossberg GT , Manes F , Allegri RF , Gutierrez-Robledo LM , Gloger S , Xie L , Jia XD , Pejovic V , Miller ML , Perhach JL , Graham SM
Ref : CNS Drugs , 27 :469 , 2013
Abstract :
PubMedSearch : Grossberg_2013_CNS.Drugs_27_469
PubMedID: 23733403

Title : Magnetic resonance imaging and neuropsychological results from a trial of memantine in Alzheimer's disease - Weiner_2011_Alzheimers.Dement_7_425
Author(s) : Weiner MW , Sadowsky C , Saxton J , Hofbauer RK , Graham SM , Yu SY , Li S , Hsu HA , Suhy J , Fridman M , Perhach JL
Ref : Alzheimers Dement , 7 :425 , 2011
Abstract :
PubMedSearch : Weiner_2011_Alzheimers.Dement_7_425
PubMedID: 21646051